Krka, a leading player in the Pharmaceutical industry, stands out as a top-tier generic pharmaceutical company globally. Founded in 1954 and headquartered in Slovenia, Krka has successfully implemented its strategies for the past 70 years, ensuring high-quality products across over 70 countries.
The company's business model is primarily centered around the production and sale of prescription pharmaceuticals, non-prescription products, and animal health solutions, with additional ventures in health resort and tourist services. Krka's commitment to innovation is evident in its focus on developing value-added generic medicines leveraging in-house expertise, ensuring efficacy and safety.
Krka's competitive edge lies in its robust investment in research and development, supported by global production and distribution infrastructure. The company places a high emphasis on fostering an international corporate culture by acquiring, motivating, and retaining talented employees. This approach not only meets but exceeds customer requirements, aligning with Krka's firm dedication to quality and operational excellence.